Pricing remdesivir: Will Gilead profit from the COVID-19 treatment?

·

·

Pricing remdesivir: Will Gilead profit from the COVID-19 treatment?

Remdesivir has emerged as the next potential COVID-19 treatment. The antiviral drug has shown promise to speed recovery in patients with COVID-19 in initial studies. Gilead, the maker of remdesivir, has been in the spotlight due to the success of the drug.
See Original Article

Forensic Accounting Market Growth by Top Companies, Trends by Types and Application, Forecast …

The research report on the Forensic Accounting Market offers a comprehensive study on market share, size, growth aspects, and major players.
See Original Article

CBD Guide for Anxiety: Can CBD Help Relieve Anxiety and Other Mental Health Disorders?

This article was originally published on cbdseniors.com. To view the original article, click here. People who struggle with generalized anxiety and other anxiety disorders need a safe form of effective relief in order to help with debilitating symptoms. For years …
See Original Article

China's Tencent Reaps Revenue of Lockdown Gaming Boom

HONG KONG — High demand for video games during COVID-19 lockdowns buoyed Tencent Holdings’ first-quarter revenue and profits, with blockbuster games PlayerUnknown’s Battlegrounds Mobile and Honor of Kings helping it beats forecasts. Get For …
See Original Article

US Stock Futures Drift Up as Investors Await Powell's Speech

U.S. stock futures edged higher Wednesday as investors await Federal Reserve Chairman Jerome Powell’s comments about the outlook for monetary policy. Futures tied to the Dow Jones Industrial Average ticked up 0.7%, suggesting the blue-chip index may …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.